Skip to main content
Eli LillyLinkedIn

Lilly presents 52-week exploratory analyses of two medicines for psoriatic arthritis and obesity.

Source: Autobound Signal API · 114 signals tracked for Eli Lilly · updated

Get Eli Lilly's live signals in Claude or ChatGPT, or by API

AskWhat changed at Eli Lilly this week? Use Autobound signals for lilly.com.

Source

LinkedInNov 11, 2026
likes
117
comments
5

Post

For people living with psoriatic arthritis (PsA) and obesity, meaningful progress isn’t defined by a single measure. Beyond disease activity, it can also be reflected in fatigue, physical function and other outcomes that matter to daily life. New 52-week exploratory analyses from the Phase 3b TOGETHER-PsA study showed improved and durable efficacy with two Lilly medicines used together to treat PsA and obesity. The results spanned PsA disease activity, patient-reported and metabolic outcomes. Explore the results presented at #ACR2026 and published in Arthritis & Rheumatology: https://lnkd.in/ecvMi6V7

linkedin.com/posts/eli-lilly-and-company_acr2026-activity-75263007679...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

More LinkedIn signals at other companies

The full record

From the Signal API record

Topics and mentions

Tags

  • Pharmaceuticals
  • Medical Research

Initiatives

  • Phase 3b TOGETHER-PsA study results

Extraction

Detected
Nov 11, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Eli Lilly and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Eli Lilly this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/179cafcb-6c66-412a-b98b-f9d38dac7b80 returns this record as JSON. POST /v1/companies/enrich returns every signal for lilly.com.

{
  "signal_id": "179cafcb-6c66-412a-b98b-f9d38dac7b80",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-11-11T15:12:14.976+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "tags": [
      "Pharmaceuticals",
      "Medical Research"
    ],
    "summary": "Lilly presents 52-week exploratory analyses of two medicines for psoriatic arthritis and obesity.",
    "post_url": "https://www.linkedin.com/posts/eli-lilly-and-company_acr2026-activity-7526300767914270720-NvOg",
    "num_likes": 117,
    "post_text": "For people living with psoriatic arthritis (PsA) and obesity, meaningful progress isn’t defined by a single measure. Beyond disease activity, it can also be reflected in fatigue, physical function and other outcomes that matter to daily life. \n \nNew 52-week exploratory analyses from the Phase 3b TOGETHER-PsA study showed improved and durable efficacy with two Lilly medicines used together to treat PsA and obesity. The results spanned PsA disease activity, patient-reported and metabolic outcomes. \n \nExplore the results presented at #ACR2026 and published in Arthritis & Rheumatology: https://lnkd.in/ecvMi6V7",
    "initiatives": [
      {
        "topic": "Phase 3b TOGETHER-PsA study results",
        "urgency": 0.4
      }
    ],
    "posted_date": "2026-11-11T15:12:14.976Z",
    "num_comments": 5
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.